A One‐Strength Dose Escalation Regimen for Birch Pollen <scp>SCIT</scp> Is Safe and Tolerable in Children, Adolescents, and Adults

Birch pollen SCIT was safe and well-tolerated when administered using a One-Strength dose-escalation regimen in patients aged 5-65 years.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2026-02-23
DOI
https://doi.org/10.1111/all.70265
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A One‐Strength Dose Escalation Regimen for Birch Pollen SCIT Is Safe and Tolerable in Children, Adolescents, and Adults

Kristina Duwensee, Marek Jutel, M. Gerstlauer, Ludger Klimek et al.
Allergy
Allergic Rhinitis and Sensitization
article

A One‐Strength Dose Escalation Regimen for Birch Pollen SCIT Is Safe and Tolerable in Children, Adolescents, and Adults

Kristina Duwensee, Marek Jutel, M. Gerstlauer, Ludger Klimek, Dana Troyke
article en

Abstract

Birch pollen SCIT was safe and well-tolerated when administered using a One-Strength dose-escalation regimen in patients aged 5-65 years.

Allergy
University Hospital Augsburg (DE), Wroclaw Medical University (PL), Zentrum für Rhinologie und Allergologie (DE), University Hospital Carl Gustav Carus (DE)
Zero hunger
Openalex Percentile: Top 39%
Allergic Rhinitis and Sensitization
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.